Cargando…
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers
AIM: AT-rich interaction domain 1A (ARID1A) encodes a key component of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex that participates in gene expression. ARID1A alterations are quite common among cancer patients, although their role remains debated. The aim of this artic...
Autores principales: | Falcone, Rosa, Filetti, Marco, Lombardi, Pasquale, Altamura, Valeria, Paroni Sterbini, Francesco, Scambia, Giovanni, Daniele, Gennaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497392/ https://www.ncbi.nlm.nih.gov/pubmed/37711591 http://dx.doi.org/10.37349/etat.2023.00163 |
Ejemplares similares
-
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings
por: Lombardi, Pasquale, et al.
Publicado: (2023) -
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years
por: Falcone, Rosa, et al.
Publicado: (2022) -
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients
por: Falcone, Rosa, et al.
Publicado: (2023) -
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
por: Duranti, Simona, et al.
Publicado: (2021) -
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid
por: Pecce, Valeria, et al.
Publicado: (2020)